UK markets close in 3 hours 42 minutes

VXRT Jan 2025 1.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.55000.0000 (0.00%)
As of 12:33PM EDT. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    Vaxart Provides Business Update

    — Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and norovirus programs — SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today provided business and cash runway updates as the Company continues to advance its oral pill vaccine platform. Vaxart anticipates that net proceeds

  • Benzinga

    Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering

    Vaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23% at one point. Vaxart’s average session volume was about 1.6 million. Friday premarket’s session volume had exceeded four million at the time of writing. Yesterday, Vaxart obtained a project award worth $453 million through the Rapid Response Partnership Vehicle, supported by the Biomedical Advanced Research and Development Authority under the Administration for Strategic Preparedness and Response

  • GlobeNewswire

    Vaxart Announces $40 Million Underwritten Offering of Common Stock

    SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart”) (Nasdaq: VXRT) today announced an underwritten offering of 50,000,000 shares of its common stock at an offering price of $0.80 per share, which is a premium to the last closing price of $0.75 per share. Gross proceeds to Vaxart from the offering are expected to be $40 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Vaxart. The offering is expected to